Biochemical analyses showed increased concentrations of plasma BCAA (Fig. 1c and Fig. S1a), along with a significant accumulation of alloisoleucine, a pathognomonic marker of MSUD (Fig. 1c), and increased concentrations of plasma BCKA (Fig. S1b). This evidence concerns the gene ARID4B and maple syrup urine disease.